JPRN-UMIN000000930已完成未知
Secondary Protective effect of ca-antagonist for ischemic heart attack randominzed parallel comparison with beta-blocker trial - SPECIA
ippon Medical School0 个研究点目标入组 800 人开始时间: 2007年12月4日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 800
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) previous history of hypersensitivity or intolerance of atenolol or benidipine 2) cardiogenic shock 3)diabetic ketoacidosis, metabolic acidosis 4)severe or symptomatic bradycardia, atrioventricular block (II, III degree), sinoatrial block, sick sinus syndrome 5)critical arrhythmia 6)right ventricular failure with pulmonary hypertension 7)congestive heart failure 8)hypotension 9)severe peripheral arterial disease (gangrene etc) 10)untreated pheochromocytoma 11)any women who is pregnant or breastfeeding, or expecting to conceive within the projected duration of the study 12)severe hepatic failure (total bilirubin >2.0mg/dL) 13)severe renal failure (serum creatinin >3.0mg/dL) 14)infection, paralytic or obstractive ileus 15)ongoing or planning treatment with anti-cancer drugs 16)other serious illness or significant abnormalities that the investigator judges inappropriate for the study
研究者
相似试验
招募中
不适用
The effect of AT1 receptor blocker/Ca antagonist combination drug on hypertensive patients - Effect of change in medication from AT1 receptor blocker/Ca antagonist concurrent dosage to its combination drugHypertensionJPRN-UMIN000007701Chiba University Hospital100
已完成
4 期
Early pharmacological treatment with supportive care versus supportive care alone in preterm infants with a patent ductus arteriosuspreterm infantsReproductive Health and Childbirth - Complications of newbornCardiovascular - Other cardiovascular diseasespatent ductus arteriosusACTRN12616000195459Hunter Medical Research Institute71
进行中（未招募）
1 期
CAPHI. Profylactic effect of Ca2+ sensitizer versus phosphodiesterase inhibitor infusion at CAGB patients with preoperative low ejection fraction. A prospective randomised clinical trial. - CAPHIEUCTR2004-002653-31-DKOdense University hospital40
招募中
3 期
Prophylactic effect of N-acetyl-cysteine plus Atorvastatin versus N-acetyl-cysteine and Atorvastatin alone for the prevention of contrast induced nephropathyContrast induced nephropathy.Other complications following infusion, transfusion and therapeutic injectionT80.8IRCT20180417039347N1Zahedan University of Medical Sciences250
尚未招募
不适用
The effectiveness of ACE-Inhibitor for preventing pneumonia; Systematic review and meta-analysisPneumoniaJPRN-UMIN000039424Shiga University of Medical Science Hospital, Department of family medicine